Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Bayer HealthCare LLC
WARNING LETTER
•Bayer HealthCare LLC

Bayer HealthCare LLC – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Bayer HealthCare L.L.C. regarding "BAYER WOMEN'S Low Dose Aspirin + CALCIUM," marketed as a combination OTC drug-dietary supplement. The product, containing 81 mg aspirin and 300 mg elemental calcium, is labeled for pain relief, aspirin regimen, and calcium supplementation to strengthen bones and fight osteoporosis.

The FDA determined the entire product is an unapproved new drug under sections 201(g)(1)(B), 201(g)(1)(C), and 201(g)(1)(D) of the Federal Food, Drug, and Cosmetic Act (the Act). Its intended uses for mitigating, treating, or preventing cardiovascular diseases and osteoporosis, combined with aspirin and calcium carbonate as active drug ingredients, render it a new drug not generally recognized as safe and effective (section 201(p) of the Act) and lacking an approved new drug application (section 505(a) of the Act).

The product is also misbranded under section 502(f)(1) of the Act due to inadequate directions for use, as osteoporosis treatment and cardiovascular indications require professional supervision. Furthermore, it is misbranded under sections 502(f)(2) and 502(a) of the Act because its labeling contains inadequate and misleading warnings. The "Drug Facts" panel warnings (e.g

Company
Bayer HealthCare LLC
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Deborah M. Autor (Former FDA Deputy Commissioner)
  • Kevin M. Budich
View Company Profile

ID · be729db2-a69e-40d9-8ceb-9f1985252722

Violation Codes10
21 CFR 343.8021 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 32121 CFR 310.3(h)21.U.S.C. 355(a)21 CFR 201.521 U.S.C. 352(f)(1)21 U.S.C. 352(f)(2)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bayer HealthCare LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.